Therapy (Hepatitis C)

Interferon Treatments Generate Autoantibodies In Adrenal Cortex

Published in Hepatitis Weekly, April 2nd, 2001

by Sonia Nichols, staff medical writer - New research performed in Germany indicates interferon-alpha therapy for hepatitis C virus (HCV) generates a low level of adrenal autoantibodies in some patients.

Previous studies have shown a link between viral hepatitis, immune therapies, and the development of autoimmune disorders originating in glands such as the thyroid. The latest study has shown that some patients generate autoantibodies to protein antigens in the adrenal cortex as well as in the thyroid and pancreas.

B. Wesche et al. assayed the sera of 75 chronic hepatitis C patients who took weekly doses of interferon (IFN)-alpha therapy for an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry